Integrated Diagnostics Holdings plc

IDGXF

IDGXFIntegrated Diagnostics Holdings plc US flag

Other OTC

0.32

USD

- -

0.04EPS

8.00P/E

186.02MMarket Cap

Aug 28Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

JE00BLKGSR75

Return %

Stock

S&P500

3.90

10.14

-52.98

62.89

-57.33

93.94

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	- -	1.12	1.43	1.69	1.95	2.52	3.2	3.71	4.43	8.71	6.01	6.87	9.64	5.87
Basic EPS, GAAP	- -	0.1	0.22	0.24	0.43	0.62	0.84	0.85	0.99	2.35	0.9	0.85	1.82	0.57
Free Cash Flow per Basic Share	- -	0.31	0.38	0.22	0.58	0.41	0.37	0.8	1.26	3.34	-0.17	0.36	2.26	0.01
Dividend per Share	- -	0.45	0.39	0.01	0.15	0.63	0.72	0.75	0.75	0.8	2.35	- -	0.05	2.2
Book Value per Share	- -	-0.31	1.79	2.03	2.31	2.31	2.45	2.55	2.79	4.37	3.09	3.92	4.8	3.47
Tangible Book Value per Share	- -	0.41	0.33	0.56	1.08	1.09	1.21	1.17	1.28	1.89	1.24	2.32	2.85	1.88
Basic Weighted Avg Shares	- -	600	600	600	600	600	600	600	600	600	600	600	594	600
Sales/Revenue/Turnover	- -	672	860	1,015	1,171	1,514	1,921	2,226	2,656	5,225	3,605	4,123	5,720	3,523
Operating Margin (%)	- -	20.88	30.14	27.91	40.09	36.05	36.15	35.91	38.69	43.77	24.21	19.17	21.22	16.87
Depreciation Expense	- -	145	116	36	45	62	77	153	185	239	317	401	483	367
Net Income, GAAP	- -	62	133	145	260	374	502	511	594	1,413	541	510	1,077	342
Effective Tax Rate (%)	- -	50.6	42.7	43.54	31.3	31.28	30.73	33.45	37.11	33.14	38.31	36.48	29.95	41.86
Profit Margin (%)	- -	9.25	15.43	14.28	22.24	24.7	26.13	22.95	22.36	27.04	15.01	12.38	18.84	9.72
Working Capital	191	188	129	198	498	494	386	210	351	694	160	687	916	386
LT Debt	2	1	1	60	120	139	167	358	466	722	1,008	959	1,011	80
Total Equity	2,069	1,946	1,805	1,942	2,299	2,314	2,401	2,360	2,426	2,794	2,447	3,101	3,499	2,852
Return on Invested Capital (%)	- -	3.35	7.55	7.94	13.78	14.52	17.86	18.41	21.02	42.33	13.97	12.8	18.24	12.9
Return on Capital (%)	- -	-70.65	25.55	11.26	17.71	23	29.93	28.35	27.59	46.01	17.98	17.64	27.92	20.34
Return on Common Equity (%)	- -	- -	- -	12.67	20.01	26.94	35.14	34.08	37.07	65.71	24.16	24.25	41.4	17.95

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	24.35%	27.62%	38.74%
Net Income, GAAP	36.63%	39.57%	111.14%
Free Cash Flow	51.2%	63.57%	517.27%
Total Cash Common Dividend	- -	- -	-98.06%
Total Equity	7.38%	9.02%	12.86%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Hend El Sherbini
Full Time Employees: 6,309
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Address: 12 Castle Street Saint Helier Jersey JE2 3RT
IPO Date: Jun 3, 2019
Website: idhcorp.com
Similar Companies: HTG Molecular Diagnostics, Inc. (HTGM)
Izotropic Corporation (IZO.CN)
Quest Diagnostics Incorporated (DGX)
Qiagen N.V. (QIA.DE)
Enzo Biochem, Inc. (ENZB)
PerkinElmer, Inc. (PKI)
Business: Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	- -	1.12	1.43	1.69	1.95	2.52	3.2	3.71	4.43	8.71	6.01	6.87	9.64	5.87
Basic EPS, GAAP	- -	0.1	0.22	0.24	0.43	0.62	0.84	0.85	0.99	2.35	0.9	0.85	1.82	0.57
Free Cash Flow per Basic Share	- -	0.31	0.38	0.22	0.58	0.41	0.37	0.8	1.26	3.34	-0.17	0.36	2.26	0.01
Dividend per Share	- -	0.45	0.39	0.01	0.15	0.63	0.72	0.75	0.75	0.8	2.35	- -	0.05	2.2
Book Value per Share	- -	-0.31	1.79	2.03	2.31	2.31	2.45	2.55	2.79	4.37	3.09	3.92	4.8	3.47
Tangible Book Value per Share	- -	0.41	0.33	0.56	1.08	1.09	1.21	1.17	1.28	1.89	1.24	2.32	2.85	1.88
Basic Weighted Avg Shares	- -	600	600	600	600	600	600	600	600	600	600	600	594	600
Sales/Revenue/Turnover	- -	672	860	1,015	1,171	1,514	1,921	2,226	2,656	5,225	3,605	4,123	5,720	3,523
Operating Margin (%)	- -	20.88	30.14	27.91	40.09	36.05	36.15	35.91	38.69	43.77	24.21	19.17	21.22	16.87
Depreciation Expense	- -	145	116	36	45	62	77	153	185	239	317	401	483	367
Net Income, GAAP	- -	62	133	145	260	374	502	511	594	1,413	541	510	1,077	342
Effective Tax Rate (%)	- -	50.6	42.7	43.54	31.3	31.28	30.73	33.45	37.11	33.14	38.31	36.48	29.95	41.86
Profit Margin (%)	- -	9.25	15.43	14.28	22.24	24.7	26.13	22.95	22.36	27.04	15.01	12.38	18.84	9.72
Working Capital	191	188	129	198	498	494	386	210	351	694	160	687	916	386
LT Debt	2	1	1	60	120	139	167	358	466	722	1,008	959	1,011	80
Total Equity	2,069	1,946	1,805	1,942	2,299	2,314	2,401	2,360	2,426	2,794	2,447	3,101	3,499	2,852
Return on Invested Capital (%)	- -	3.35	7.55	7.94	13.78	14.52	17.86	18.41	21.02	42.33	13.97	12.8	18.24	12.9
Return on Capital (%)	- -	-70.65	25.55	11.26	17.71	23	29.93	28.35	27.59	46.01	17.98	17.64	27.92	20.34
Return on Common Equity (%)	- -	- -	- -	12.67	20.01	26.94	35.14	34.08	37.07	65.71	24.16	24.25	41.4	17.95

	Dec'22	Mar'23	Jun'23
Total Current Assets	1,625	1,720	1,701
Accounts Receivable, Net	395	467	532
Cash, Cash Equivalents & STI	816	813	689
Inventories	265	296	361
Total Current Liabilities	1,465	1,371	1,315
Payables & Accruals	- -	- -	- -
ST Debt	171	83	28
Deferred Revenue	- -	- -	- -

Integrated Diagnostics Holdings plc

Growth Rates

(avg. rate of change)

Company Description

Capital Structure

Quarterly Earnings Per Share

Year

Growth Rates

(avg. rate of change)

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

	Dec'22	Mar'23	Jun'23
ST Debt	171	83	28
LT Borrowings	94	80	80
LT Finance Leases	914	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	600	600	600
Market Capitalization	9,110	8,445	9,394

Year	Q1	Q2	Q3	Q4	FY
2022	0.49	0.21	-0.03	- -	0.9
2023	0.29	0.08	- -	- -	0.85
2024	0.7	- -	- -	- -	1.82

Year	Q1	Q2	Q3	Q4	FY
2022	1,180	774	846	805	3,605
2023	915	957	- -	- -	4,123
2024	1,171	1,327	- -	- -	5,720